Cargando…
Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial
BACKGROUND: Several studies have suggested that proton pump inhibitors (PPIs) may reduce the antiplatelet effects of clopidogrel and/or aspirin, possibly leading to cardiovascular events. AIMS: We aimed to investigate the association between PPI and clinical outcomes in patients treated with ticagre...
Autores principales: | Ono, Masafumi, Onuma, Yoshinobu, Kawashima, Hideyuki, Hara, Hironori, Gao, Chao, Wang, Rutao, O'Leary, Neil, Benit, Edouard, Janssens, Luc, Ferrario, Maurizio, Żurakowski, Aleksander, Dominici, Marcello, Huber, Kurt, Buszman, Paweł, Garg, Scot, Wykrzykowska, Joanna J., Piek, Jan J., Jüni, Peter, Hamm, Christian, Windecker, Stephan, Vranckx, Pascal, Deliargyris, Efthymios N., Bhatt, Deepak L., Storey, Robert F., Valgimigli, Marco, Serruys, Patrick W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541955/ https://www.ncbi.nlm.nih.gov/pubmed/35500171 http://dx.doi.org/10.1002/ccd.30217 |
Ejemplares similares
-
Mortality after multivessel revascularisation involving the proximal left anterior descending artery
por: Ono, Masafumi, et al.
Publicado: (2022) -
Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre‐Specified Analysis of the GLOBAL LEADERS Trial
por: Vranckx, Pascal, et al.
Publicado: (2021) -
Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020) -
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
por: Gragnano, Felice, et al.
Publicado: (2022) -
Intraoperative ticagrelor removal via hemoadsorption during on-pump coronary artery bypass grafting
por: Hassan, Kambiz, et al.
Publicado: (2023)